Objectives

• Identify the proportion of economic evaluation incorporating labour productivity losses and non-healthcare costs

• Identify pathologies where it is more frequent to include social costs in economic evaluations

• Identify the countries where it is more frequent the inclusion of social costs in economic evaluations

• Compare the results of the economic evaluations achieved in case studies that incorporate social costs with the results of the studies not including social costs in the same studies

• Identify the methodology used in the assessment of labour productivity losses, formal and informal care.

• Elaborate a repository on unit costs in Europe of lost work time and the value of informal care time (coordinated part with WP3).

​

Methodology

• Literature review: Revising the methodological aspects related to applied to the identification, measurement and valuation of social costs, especially, labour losses and informal care cost in economic evaluations

• Case studies: Quantifying different ways of incorporating the social perspective into economic analysis to inform European decisions

• European Database: Creating a database on unit costs in Europe of lost work time and the value of informal and formal care time (coordinated part with WP3).

​

Outputs

• Deliverable D4.1: Revising the methodological aspects applied to the identification, measurement and valuation of social costs in economic evaluations [PDF]
   

• Deliverable D4.2: How relevant is the societal perspective in economic evaluations? Evidence from five case studies [PDF]
   

• Deliverable D4.3: Core dataset of social costs. Creating a database on unit costs in Europe of lost work time and the value of informal and formal care time of unit costs of health services [PDF]
   

• Work Package Overall Results [Poster PDF]
   

• European Healthcare and Social Cost Database (EU HCCD)

The EU HCCD provides a core dataset of costs across countries. It allows analysis of variations in costs within/across countries (taking into account differences between healthcare systems and other factors) and health economic evaluations (by transfer of economic evaluation analysis and models across countries). Additionally, it facilitates multi-country studies and the adaptation of economic evaluation studies from country to country by reducing the time/costs of finding healthcare costs.

Access the database HERE.

 

Publications

• Aranda-Reneo I, Peña-Longobardo LM, Rodríguez-Sánchez B, Oliva-Moreno J, López-Bastida J. How relevant are social costs in economic evaluations? The case of Alzheimer’s disease, Jornadas de Economía de la Salud, 2019 [PDF]
   

• Peña-Longobardo LM, Rodríguez-Sánchez B, Oliva-Moreno J, Aranda-Reneo I, López-Bastida J. (2019). How relevant are social costs in economic evaluations? The case of Alzheimer’s disease. The European Journal of Health Economics, 20(8), 1207–1236. [https://doi.org/10.1007/s10198-019-01087-6]
   

• López-Bastida J, Aranda-Reneo I, Peña-Longobardo LM, Rodríguez-Sánchez B, Oliva-Moreno J. How relevant are social costs in economic evaluations? The case of Rare Diseases – ISPOR 2019 [Poster PDF]
   

• Juliane Andrea Duevel, Lena Hasemann, Luz Maria Peña-Longobardo, Beatriz Rodríguez-Sánchez, Isaac Aranda-Reneo, Juan Oliva-Moreno, Julio López-Bastida, Wolfgang Greiner (2020). Considering the societal perspective in economic evaluations: a systematic review in the case of depression. Health Economics Review, 2020,10 (1):32 [https://doi.org/10.1186/s13561-020-00288-7]
   

• López-Bastida J, Rodríguez-Sánchez B, Aranda-Reneo I, Oliva-Moreno J. Assessing the effect of including social costs in economic evaluations: A systematic review of diabetes-related interventions – ISPOR 2020 [Poster PDF]
   

•  López-Bastida J, Düvel AJ, Hasemann L, Peña-Longobardo L.M, Rodríguez-Sánchez B, Aranda-Reneo I, Oliva-Moreno J, Greiner W. Considering the societal perspective in economic evaluations: a systematic review in the case of depression – ISPOR 2020 [Poster PDF]
   

• López-Bastida J, Cichetti A, Rodríguez-Sánchez B, Daugberg S, Peña-Longobardo L.M, Aranda-Reneo I, Oliva-Moreno J. Social costs in multiple sclerosis economic evaluations: do their inclusion change the results and conclusions? A systematic review – ISPOR 2020 [Poster PDF]
   

• Aranda-Reneo I, Rodríguez-Sánchez B, Peña-Longobardo LM, Oliva-Moreno J, López-Bastida J. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis. Value Health. 2021 Mar;24(3):431-442. doi: 10.1016/j.jval.2020.10.014. Epub 2020 Dec 5. PMID: 33641778. [Read on PubMed]
   

• Rodriguez-Sanchez B, Aranda-Reneo I, Oliva-Moreno J, Lopez-Bastida J. Assessing the Effect of Including Social Costs in Economic Evaluations of Diabetes-Related Interventions: A Systematic Review. Clinicoecon Outcomes Res. 2021 Apr 29;13:307–334. [https://doi.org/10.2147/ceor.s301589]

​

• Rodríguez‑Sánchez B, Daugbjerg S, Peña‑Longobardo LM, Oliva‑Moreno J, Aranda‑Reneo I, Cicchetti A, López‑Bastida J (2022) Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease. The European Journal of Health Economics [https://doi.org/10.1007/s10198-022-01471-9]